These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 9870475)

  • 1. Assessment of ultrasound guided percutaneous ethanol injection and parathyroidectomy in patients with tertiary hyperparathyroidism.
    Fletcher S; Kanagasundaram NS; Rayner HC; Irving HC; Fowler RC; Brownjohn AM; Turney JH; Will EJ; Davison AM
    Nephrol Dial Transplant; 1998 Dec; 13(12):3111-7. PubMed ID: 9870475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosis of parathyroid function after successful percutaneous ethanol injection therapy guided by color Doppler flow mapping in chronic dialysis patients.
    Kakuta T; Fukagawa M; Fujisaki T; Hida M; Suzuki H; Sakai H; Kurokawa K; Saito A
    Am J Kidney Dis; 1999 Jun; 33(6):1091-9. PubMed ID: 10352197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tertiary hyperparathyroidism treated by ultrasonically guided percutaneous fine-needle ethanol injection.
    Cintin C; Karstrup S; Ladefoged SD; Joffe P
    Nephron; 1994; 68(2):217-20. PubMed ID: 7830859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical ablation of recurrent and persistent secondary hyperparathyroidism after subtotal parathyroidectomy.
    Chen HH; Lin CJ; Wu CJ; Lai CT; Lin J; Cheng SP; Yang TL
    Ann Surg; 2011 Apr; 253(4):786-90. PubMed ID: 21475021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful ultrasonically guided percutaneous ethanol injection for secondary hyperparathyroidism.
    Takeda S; Michigishi T; Takazakura E
    Nephron; 1992; 62(1):100-3. PubMed ID: 1436272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intervention for recurrent secondary hyperparathyroidism from a residual parathyroid gland.
    Yumita S
    Nephrol Dial Transplant; 2003 Jun; 18 Suppl 3():iii62-4. PubMed ID: 12771304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term (3 years) prognosis of parathyroid function in chronic dialysis patients after percutaneous ethanol injection therapy guided by colour Doppler ultrasonography.
    Tanaka R; Kakuta T; Fujisaki T; Tanaka S; Sakai H; Kurokawa K; Saito A
    Nephrol Dial Transplant; 2003 Jun; 18 Suppl 3():iii58-61. PubMed ID: 12771303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of functioning parathyroid cell mass by ethanol injection in chronic dialysis patients.
    Kitaoka M; Fukagawa M; Ogata E; Kurokawa K
    Kidney Int; 1994 Oct; 46(4):1110-7. PubMed ID: 7861705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous ethanol injection therapy: a surgery-sparing treatment for primary hyperparathyroidism.
    Stratigis S; Stylianou K; Mamalaki E; Perakis K; Vardaki E; Tzenakis N; Katsipi I; Papavasiliou S; Yarmenitis S; Kyriazis J; Daphnis E
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):542-8. PubMed ID: 18331604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute change in parathyroid function in primary hyperparathyroidism following ultrasonically guided ethanol injection into solitary parathyroid adenomas.
    Karstrup S; Hegedüs L; Holm HH
    Acta Endocrinol (Copenh); 1993 Nov; 129(5):377-80. PubMed ID: 8279217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrasound-guided chemical parathyroidectomy in patients with primary hyperparathyroidism: a prospective study.
    Karstrup S; Transbøl I; Holm HH; Glenthøj A; Hegedüs L
    Br J Radiol; 1989 Dec; 62(744):1037-42. PubMed ID: 2691006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperparathyroidism caused by distant pulmonary lesions and parathyromatosis after ethanol injection/parathyroidectomy for secondary hyperparathyroidism.
    Nakamura M; Tanaka K; Fujii T
    Hemodial Int; 2017 Jul; 21(3):E45-E49. PubMed ID: 28078796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasound-guided percutaneous fine-needle ethanol injection into parathyroid glands in secondary hyperparathyroidism.
    Giangrande A; Castiglioni A; Solbiati L; Allaria P
    Nephrol Dial Transplant; 1992; 7(5):412-21. PubMed ID: 1321377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasound-guided percutaneous ethanol ablation of parathyroid hyperplasia: preliminary experience in patients on chronic dialysis.
    Schamp S; Dünser E; Schuster H; Kramer-Deimer J; Kettenbach J; Funovics M; Lang U; Meisl FT; Umek H
    Ultraschall Med; 2004 Apr; 25(2):131-6. PubMed ID: 15085455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical verification of percutaneous maxacalcitol injection therapy on enlarged parathyroid glands in chronic dialysis patients.
    Yamamoto H; Katoh N; Takeyama H; Ikeda M; Yokoyama K; Shigematsu T; Kawaguchi Y; Hosoya T
    Nephrol Dial Transplant; 2003 Jun; 18 Suppl 3():iii50-2. PubMed ID: 12771301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of percutaneous ethanol injection therapy (PEIT) is related to the number of parathyroid glands in haemodialysis patients with secondary hyperparathyroidism.
    Koiwa F; Kakuta T; Tanaka R; Yumita S
    Nephrol Dial Transplant; 2007 Feb; 22(2):522-8. PubMed ID: 17127701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasonically guided chemical parathyroidectomy in patients with primary hyperparathyroidism: a follow-up study.
    Karstrup S; Hegedüs L; Holm HH
    Clin Endocrinol (Oxf); 1993 May; 38(5):523-30. PubMed ID: 8330447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Percutaneous ethanol injections in the treatment of secondary hyperparathyroidism].
    Kuzdak K; Rybińska A; Białas M
    Endokrynol Pol; 2005; 56(6):891-6. PubMed ID: 16821207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local ethanol injection for the treatment of deltoid parathyroid cell hyperplasia.
    Figari M; Musso CG; Plantalech L; Lambertini R; Rivera H; Mollerach A
    Int Urol Nephrol; 2014 Jan; 46(1):247-9. PubMed ID: 23359107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parathyroidectomy for tertiary hyperparathyroidism associated with X-linked dominant hypophosphatemic rickets.
    Savio RM; Gosnell JE; Posen S; Reeve TS; Delbridge LW
    Arch Surg; 2004 Feb; 139(2):218-22. PubMed ID: 14769584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.